The Division of Drug Marketing, Advertising, and Communications (DDMAC) of the U.S. Food and Drug Administration (FDA), is pleased to inform you of a unique opportunity to participate in our second Enforcement Webinar, which was held on August 25, 2011. This is a pilot program in which DDMAC will give our stakeholders a chance to directly communicate with the Agency on clarifications or questions about the Warning Letters and Untitled Letters issued by DDMAC in a given quarter. This particular webinar covered Warning Letters and Untitled Letters issued from May 2011 to August 2011.
The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.